Search - tctmd.com

Displaying 101 - 120 of 59348

Sort: Relevancy | Date

Presentation THT 2026

Cardiogenic Shock Working Group: Triumphs and Tribulations

Presenter: Rachna Kataria

March 04, 2026

Presentation THT 2026

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Presenter: Theo Mastrokostopoulos

March 04, 2026

Presentation THT 2026

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

Presenter: Tom Heywood

March 04, 2026

Presentation THT 2026

VENUS Patch™:A Dual-Site, Noninvasive Venous Congestion Sensor for Early Detection of Heart Failure Decompensation

Presenter: Juliana Giorgi

March 04, 2026

Presentation THT 2026

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Presenter: Tor Biering-Sørensen

March 04, 2026

Presentation THT 2026

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

Presenter: Thierry Sarda

March 04, 2026

Presentation THT 2026

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Presenter: Issa Dahabreh

March 04, 2026

Presentation THT 2026

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Presenter: Sudhir Kushwaha

March 04, 2026

Presentation THT 2026

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Presenter: Robert W. Yeh

March 04, 2026

Presentation THT 2026

Opening Remarks

Presenter: Grzegorz L. Kaluza

March 04, 2026

Presentation THT 2026

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Presenter: Remi Sabatier

March 04, 2026

Presentation THT 2026

Time for a Separate Guideline Path for HF Devices?

Presenter: Javed Butler

March 04, 2026

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

Presentation THT 2026

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Presenter: James Januzzi

March 04, 2026

Presentation THT 2026

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

Presenter: Sriram Nathan

March 04, 2026

Presentation THT 2026

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Presenter: Gregg W. Stone

March 04, 2026

Presentation THT 2026

Early Feasibility Study Of Using Venous Waveform Analysis To Estimate Right Atrial Pressures In Patients Going For Right Heart Catheterization

Presenter: Bret Alvis

March 04, 2026

Presentation THT 2026

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

Presenter: John A. Spertus

March 04, 2026

Presentation THT 2026

First Reported Real-World Outcomes of the Bodyport Cardiac Scale and Congestion Index in Heart Failure

Presenter: Marat Fudim

March 04, 2026

Presentation THT 2026

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Presenter: JoAnn Lindenfeld

March 04, 2026

Advertisement

Cardiogenic Shock Working Group: Triumphs and Tribulations

The PleioFlow Transcather Valve-powered Flow Pump - Next-Generation ultra-low profile physiologic circulatory support for patients in early stage Cardiogenic Shock

Hemodynamic Frontiers in Heart Failure (HF2) Registry: Goals and Achievements

VENUS Patch™:A Dual-Site, Noninvasive Venous Congestion Sensor for Early Detection of Heart Failure Decompensation

Virtual Randomized Clinical Trials: Learnings From DANLOGIC-HF

Emyosound Real-Time 3D Myocardial Shear Wave Elastography for Quantitative Assessment of Cardiac Stiffness in Heart Failure and Cardiomyopathies

Statistical Approaches for Developing Credible Evidence of Safety and Effectiveness for HF Devices From Real World Data: An Overview for the Clinician

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Real World Databases: What Is Required for Their Use To Substitute for Randomized Trials for Device Approvals, Reimbursement and Label Expansion

Opening Remarks

Cutaneous device and machine learning could estimate pulmonary capillary wedge pressure in patients with heart failure

Time for a Separate Guideline Path for HF Devices?

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Revisiting Surrogate Endpoints in Clinical Trials of HF Devices

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

The Elephant in the Room: How To Deal With PROs in Non-Sham Controlled Studies

Early Feasibility Study Of Using Venous Waveform Analysis To Estimate Right Atrial Pressures In Patients Going For Right Heart Catheterization

Revisiting Patient Reported Outcomes — Can they Be Improved for Device Trials and Account for Mortality?

First Reported Real-World Outcomes of the Bodyport Cardiac Scale and Congestion Index in Heart Failure

The Path Most Traveled: An Overview of the Breakthrough Device Designation — Can It Be Improved?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content